✦ LIBER ✦

Prevalence studies in nosocomial infections

✍ Scribed by R. C. Spencer

Publisher: Springer
Year: 1992
Tongue: English
Weight: 495 KB
Volume: 11
Category: Article
ISSN: 0934-9723
DOI: 10.1007/bf01967059

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Nosocomial and community-acquired infect

Nosocomial and community-acquired infections in Germany. Summary of the results of the first national prevalence study (NIDEP)

✍ H. Rüden; P. Gastmeier; F. D. Daschner; M. Schumacher 📂 Article 📅 1997 🏛 Springer-Verlag 🌐 English ⚖ 693 KB

The impact of oral health and 0.2% chlor

The impact of oral health and 0.2% chlorhexidine oral gel on the prevalence of nosocomial infections in surgical intensive-care patients: a randomized placebo-controlled study

✍ Tomislav Ćabov; Darko Macan; Ino Husedžinović; Jasenka Škrlin-Šubić; Danica Bošn 📂 Article 📅 2010 🏛 Springer Vienna 🌐 English ⚖ 305 KB

Prevalence of nosocomial infections — Wh

Prevalence of nosocomial infections — Who knows the true rates?

✍ C. Ruef 📂 Article 📅 1997 🏛 Springer-Verlag 🌐 English ⚖ 558 KB

Nosocomial lower respiratory tract infec

Nosocomial lower respiratory tract infections: prevalence and risk factors in 14 Greek hospitals

✍ D. P. Kofteridis; J. A. Papadakis; D. Bouros; P. Nikolaides; G. Kioumis; S. Levi 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 78 KB

Moxalactam in nosocomial infections with

Moxalactam in nosocomial infections withSerratia marcescens

✍ T. Mall; F. Follath; M. Salfinger; R. Ritz; H. Reber 📂 Article 📅 1985 🏛 Springer 🌐 English ⚖ 402 KB

Ten critically ill patients presenting with nosocomial infection caused by Serratia marcescens (SM) not responding to prior chemotherapy were treated in an open study with Moxalactam (MOX) alone [6] or in combination with an aminoglycoside [4]. In initial disc diffusion tests, all isolates of SM wer

Nosocomial infections in intensive care

Nosocomial infections in intensive care units

✍ F. Daschner 📂 Article 📅 1985 🏛 Springer 🌐 English ⚖ 288 KB